Literature DB >> 6145805

Experimental evidence for a central nervous system site of action in the effect of alpha-adrenergic blockers on the external urinary sphincter.

J Gajewski, J W Downie, S A Awad.   

Abstract

The present study was done to test the hypothesis that alpha-adrenoceptor blocking drugs (phentolamine and prazosin) could interfere with somatic control of the external sphincter through an action in the central nervous system. Stimulation of the hypogastric nerve in the chloralose-anesthetized cat caused a urethral constriction which could be antagonized by alpha-receptor blockers. However, the constriction produced by stimulation of the S1 or S2 ventral root was completely resistant to alpha blockade. The drugs therefore had the expected action against sympathetic stimulation of the urethra but had no peripheral effect on the somatic component. The central effect of these drugs was investigated by recording urethral perfusion pressure responses, or compound action potentials on the central cut end of the pudendal nerve, evoked by stimulation of the contralateral pudendal or pelvic nerve. The urethral constriction produced by stimulation of the central cut end of 1 pudendal nerve was antagonized by both prazosin and phentolamine. Action potentials evoked on the pudendal nerve by stimulation of the central cut end of the contralateral pudendal or pelvic nerve were substantially inhibited by prazosin. Phentolamine produced a more variable blockade of the pudendal-pudendal reflex. The results strongly indicate that these alpha-adrenoceptor antagonists and especially prazosin can influence pudendal nerve-dependent urethral responses through a central nervous system action and not through a peripheral mechanism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145805     DOI: 10.1016/s0022-5347(17)49637-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

Review 1.  Innovations in pharmacotherapy for stress urinary incontinence.

Authors:  Tracy W Cannon; Naoki Yoshimura; Michael B Chancellor
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-11-20

Review 2.  Neural control of the female urethral and anal rhabdosphincters and pelvic floor muscles.

Authors:  Karl B Thor; William C de Groat
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-19       Impact factor: 3.619

3.  Pharmacotherapy for stress urinary incontinence.

Authors:  Tracy W Cannon; Michael B Chancellor
Journal:  Rev Urol       Date:  2003

4.  The role of alpha(1)-adrenoceptors and 5-HT(1A) receptors in the control of the micturition reflex in male anaesthetized rats.

Authors:  R K Conley; T J Williams; A P Ford; A G Ramage
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

5.  Duloxetine as a treatment for stress incontinence--where are we now?

Authors:  Jonathan Duckett
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-09-26

6.  The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons.

Authors:  Ulrich Mehnert; Sönke Boy; Sabina Widmer-Simitovic; André Reitz; Brigitte Schurch
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-03-07

Review 7.  Neural control of the lower urinary tract.

Authors:  William C de Groat; Derek Griffiths; Naoki Yoshimura
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

8.  A study of the alpha-1 adrenoceptor blocker prazosin in the prophylactic management of autonomic dysreflexia in high spinal cord injury patients.

Authors:  H Krum; W J Louis; D J Brown; L G Howes
Journal:  Clin Auton Res       Date:  1992-04       Impact factor: 4.435

Review 9.  Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.

Authors:  Wolfgang Jost; Parvaneh Marsalek
Journal:  Clin Auton Res       Date:  2004-08       Impact factor: 4.435

10.  Micturition in conscious rats with and without bladder outlet obstruction: role of spinal alpha 1-adrenoceptors.

Authors:  O Ishizuka; K Persson; A Mattiasson; A Naylor; M Wyllie; K Andersson
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.